Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Onabotulinum Toxin A for Direct Brow Lift Scarring
NCT04383912Active, not recruiting
- Sponsor
- Nova Scotia Health
- Start
- Nov 2020
- Primary completion
- Jul 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, double-blind trial in surgical scar comparing Botox Side with Placebo Side (2 arms). Primary endpoints: Effect of onabotulinum toxin A on scarring in direct brow lift surgery and Degree of brow lift achieved. Started Nov 2020; status: active, not recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
surgical scar
Beyond the preview
Go deeper on NCT04383912.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04383912.